Asthma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Asthma stocks.

Asthma Stocks Recent News

Date Stock Title
May 23 AZN Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
May 23 REGN 3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
May 23 AZN Nona Biosciences and AstraZeneca sign global license and option agreement
May 23 TMO Thermo Fisher Scientific declares $0.39 dividend
May 22 TMO Thermo Fisher Scientific Declares Quarterly Dividend
May 22 TMO Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells
May 22 GSK First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
May 22 AZN Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
May 22 GSK GSK Breathes New Life Into Asthma Treatment With Depemokimab
May 22 GSK Australia reports first human case of bird flu
May 22 REGN Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
May 22 AZN Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
May 22 AZN AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​
May 22 REGN Regeneron faces new biosimilar threats; an AI biotech lays off staff
May 22 AZN SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca
May 21 ATR Aptar Receives Platinum Rating from EcoVadis for the Fourth Consecutive Year
May 21 AZN AstraZeneca’s $80B sales plan leans on cancer drug expansion
May 21 GSK GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
May 21 AZN AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
May 21 AZN European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030
Asthma

Asthma is a common long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. These episodes may occur a few times a day or a few times per week. Depending on the person, they may become worse at night or with exercise.Asthma is thought to be caused by a combination of genetic and environmental factors. Environmental factors include exposure to air pollution and allergens. Other potential triggers include medications such as aspirin and beta blockers. Diagnosis is usually based on the pattern of symptoms, response to therapy over time, and spirometry. Asthma is classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. It may also be classified as atopic or non-atopic, where atopy refers to a predisposition toward developing a type 1 hypersensitivity reaction.There is no cure for asthma. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or antileukotriene agents may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. Treatment of rapidly worsening symptoms is usually with an inhaled short-acting beta-2 agonist such as salbutamol and corticosteroids taken by mouth. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required.In 2015, 358 million people globally had asthma, up from 183 million in 1990. It caused about 397,100 deaths in 2015, most of which occurred in the developing world. It often begins in childhood. The rates of asthma have increased significantly since the 1960s. Asthma was recognized as early as Ancient Egypt. The word "asthma" is from the Greek ἅσθμα, ásthma, which means "panting".

Browse All Tags